Dilution is coming once again. Remember when our CEO said when he took on the job that the old games were a thing of the past? Well that was over a billion shares ago and he is adding more before the end of this year. Any guesses how many shares will be added? New investors may want to jump in but do so at your pearl. The only thing that will move the needle up at this stage will be JV or if ACTC is sold. When I say move the needle up I’m talking maybe 50% or more which for a stock this risky is minimal amount. Our CEO has been talking about a JV for over two years. So, I doubt we see one till the results our touted in Scientific Journal and they will need to be beyond reproach because of the history of the management at ACTC. And for that to happen it will take most of the rest of this year. If it happens, which if you can’t tell I am very pessimistic about it happening. But then I’ve been a shareholder for almost three years.
I agree..thats my 2 cents..which is my target price...over 150 mil market cap for unproven junk..worth less than one third of that...Powerball tickets cost 2 bucks now...actc not even worth the price of a stick of gum.
Sentiment: Strong Sell
You clearly have no clue about the potential of this science and impact on the value of ACTC. The reverse split will allow for not only institutional investors to buy in, but also allow the Company to raise new Capital for ongoing research. Do your homework please.
My homework tells me that listing on Nasdaq will give "Shorts" a great opportunity to do what they do. Look at DNDN history to see how being listed on Nasdaq helped them. I agree the hype for Stem Cells is seducing many retail investors but until the industry as a whole not just ACTC cleans up their act listing on Nasdaq will not have the much touted affect you are hoping to see. But dreaming of the riches at the end of the rainbow is fun, so keep dreaming friend.
Can't say I disagree. Once in a while I will buy a powerball ticket knowing it will likely be worth nothing the next day. This is kind of the same thing. One good journal article away from some nice profits here. Dilution is a given and in the price somewhat I believe. Could see .06 or even in the .05 range on disappointment on "earnings" report.
Dilution is here-all week- 27,522,833 shares of our common stock to Volation. What will a JV bring to the table today? There is no saleable product. ACTC goes up when the selling stops-it's brief, but it's there.